Healthcare & Life Sciences
Achaogen
United Statesachaogen.com
Achaogen is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Achaogen
Based in the United States, Achaogen is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Achaogen developed antibiotic treatments, including ZEMDRI® (plazomicin), which was approved in the US for treating complicated urinary tract infections caused by certain multidrug-resistant Enterobacterales bacteria.
Explore Achaogen's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.